Proud to present our nationwide cohort study using 🇧🇪 Belgian Cancer Registry data (2008-2014) analyzing 51,696 early BC pts (44,088 IDC, 7,608 ILC) Lobular histology was associated with more advanced stages at diagnosis leading to worse OS, particularly in TNBC OncoAlert

A 2:16 il nostro Nicolò Gilardi di Università di Genova sull’impatto dell’#AI in #MedicinaInterna: studio con Ospedale San Martino Genova alle XI Giornate Piemontesi dei Giovani Internisti. Il futuro? Tecnologia e umanità insieme per cure migliori! #DigitalHealth #GIS youtube.com/live/tBnS1c8sp…

On this World Cancer #Research Day, we'd like to thank all the #scientific #community for making #progress happen. 🔍 #breastcancer #EU4Health HaDEA

Consensus mtg of PRECEDENT project aimed to set & report guidelines for locoregional therapies in #neoadjuvant #breastcancer trials. This project is led by Stuart McIntosh Shelley Potter under the #BIG-NCTN collab 👉 shorturl.at/MCn0A Katherine Cowan The Breast Cancer Research Foundation HaDEA

Kicking off an exciting analysis using #SpatialTranscriptomics! Plasmablast cells in immune checkpoint inhibitor-related hepatitis with 10x Genomics #Xenium. Early findings look promising! Amazing support from Ospedale San Martino Genova and Università di Genova AACR @SITCcancer #CancerResearch

Off-label and off-trial oncology drug use highlights the tension between rapid access and ensuring efficacy and safety. Regulatory challenges and patient impact remain key issues. Dario Trapani ESMO - Eur. Oncology #Oncology #CancerCare #ESMO24 #Safety OncoAlert dailyreporter.esmo.org/esmo-congress-…

Wow The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer aacrjournals.org/clincancerres/… great team Giampaolo Bianchini

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women | New England Journal of Medicine nejm.org/doi/full/10.10…

Presentato oggi alla #SIMI2024 il poster del nostro studio INTERNIST su #AI per il supporto alla diagnosi in Medicina Interna! Scopri come l’intelligenza artificiale può integrare il processo decisionale medico basato su diversi livelli di formazione Nicolò Gilardi SIMI Società Italiana Medicina Interna

Bravo Benedetta Cigolini ! At #SIMI2024, Benedetta Cigolini presented a fascinating case of cardiac sarcoidosis with systemic involvement. Complex diagnosis and positive response to steroid therapy. A great example of how a multidisciplinary approach is crucial in managing rare

Presentata alla #SIMI2024 la survey SIMI-FADOI sulla gestione del fine vita nei reparti di Medicina Interna. Un ringraziamento al nostro Mario Stabile dell’Università di Genova per l’importante contributo nel comprendere le opinioni su questo delicato tema SIMI Società Italiana Medicina Interna

Great #SIMI2024! Proud to see our #InternalMedicine school from Genova represented with high-level presentations by our fellows SIMI Società Italiana Medicina Interna Università di Genova Ospedale San Martino Genova Andrea Ceccardi Benedetta Cigolini Nicolò Gilardi. #AI #EndOfLifeCare #RareDiseases

🛡️ Cancer cells use "3 Cs" to evade the immune system: 1️⃣ Camouflage: Hiding from immune detection. 2️⃣ Coercion: Disrupting immune function. 3️⃣ Cytoprotection: Shielding from immune attacks. Blocking these mechanisms enhances immunotherapy and restores anticancer immune

Sunday reminder.

Our scientific advisor, Thayane Crestani, is at ESMO #MAP2024 in London, getting up to date on the latest in #precisiononcology, tumour profiling, AI, and much more - learning and networking to shape the future of #breastcancer care together! ESMO - Eur. Oncology HaDEA #EU4Health #bcsm

At #ESMO24 , I had the privilege to discuss with Philippe Aftimos, MD  our findings from the AURORA program. We explored how age-related molecular differences in advanced breast cancer shape unique genetic and transcriptional profiles, offering insights into personalized treatments. Our

Un grandissimo applauso a Paola Ghiorzo e Federica Grillo, professioniste straordinarie per aver organizzato con dedizione e competenza il Terzo Congresso dell’Associazione Italiana Familiarità ed Ereditarietà dei Tumori (#AIFET2024). Un evento di altissimo livello scientifico

An abstract (e23009) has now been published at #ASCO25 on the BIG - Patient Partnership model for facilitating meaningful patient involvement in the design and conduct of cancer research, click here to read: meetings.asco.org/abstracts-pres…

Unfortunately it’s clear that the Israeli people (although we are the majority since Oct 7th) can’t topple the government or change its ways. Seems like the attorney general, the last gate keeper, will be fired soon. As long as we’re stuck with this government, the war won’t